Right to Distribute. The Manufacturer has not granted and shall not, during the Term, grant, directly or indirectly, to any other person any right (whether current, future, contingent or otherwise) to sell the Product in or into the Territory.
Right to Distribute. The Distributor shall not grant, directly or indirectly, to any other person other than a Subdistributor any right to use any right or license to use any Intellectual Property within the Territory.
Right to Distribute. You may copy and distribute the sample object code and sample source code files contained in the 3D- SDK, if any (“Distributable Code”).
Right to Distribute. HBL hereby grants to ABI the exclusive right to distribute products containing HBL TNF-a for oral and topical use in human species and use by all routes of administration in non-human species worldwide, except Japan.
Right to Distribute. You grant to Parler a license to any content posted by you to the Services, including a worldwide, non-exclusive, royalty-free license (with the right to sublicense) to use, copy, reproduce, process, adapt, modify, publish, transmit, display and distribute your content. You agree that Parler or its service providers or partners may display advertising in connection with your content and otherwise monetize your content without compensation to you, unless you are a participant in our Influencer Network and then you will be compensated according to the terms of that program. You warrant that you have all rights necessary to grant these rights to Parler and other members of the Parler community. You also grant a limited non-exclusive, royalty-free license to any Parler community member to use, copy, reproduce, process, adapt, modify, publish, transmit, display, and distribute any content posted by you to the Services solely in connection with that member’s use of the Services. The licenses granted by you hereunder do not include any moral rights or right of attribution.
Right to Distribute. 1. Tauriga, as the owner and/or exclusive licensee of the Trademarks and all of the other proprietary trade dress, package, designs, logos related thereto (the “Other IP” Inclusive “USPTO filed Trademark for Tauri-GumTM” filed for by Tauriga Sciences Inc. during December 2018) in and to the Products and Tauriga hereby grants to SKL a non-exclusive right to distribute the Products under the terms of this Agreement in the NJ and Northeast Region of USA.
2. Tauriga will contemplate granting to SKL an exclusive license to SKL to market and distribute its Tauri-GumTM product line — for the NJ market at a later time, should both parties deem it in the best interests of all parties (by mutual Agreement).
3. Tauriga shall make inventory available to SKL, as requested by SKL to fulfill orders. All net revenue earned & realized by Tauriga shall be deposited into Tauriga’s dedicated Revenue Intake ACCT at TD Bank.
4. The parties (Tauriga and SKL) acknowledge and agree that the initial target customers shall be spirits stores, convenient stores, pharmacies, etc. that believe that a legal CBD Infused Supplement Gum may be a desirable option for some patients. Tauriga makes the following point(s) clear: The Company shall NOT EVER make any medical claims or treatment claims with respect to this product — it is simply characterized and classified as a SUPPLEMENT CHEWING GUM containing 10mg of CBD Isolate per serving ( 1 serving — 1 piece of Gum).
Right to Distribute. 1.1 CTT hereby grants Distributor the right to purchase from CTT, and the exclusive right to resell solely within the Territory (as defined hereinafter) for use within the Territory, the Pain Management Therapy Device. Distributor agrees that, except as specifically permitted in Section 1.5 herein, it will not purchase the Pain Management Therapy Device from any person or entity other than CTT. "Territory" shall mean the following territories: United States of America, Guam and United States of America possessions, U.S. Virgin Islands, Bahamas, Bermuda and Puerto Rico, but only for so long, and to the extent, that the offer and/or sale of the Pain Management Therapy Device is legally permissible in such territories. Notwithstanding the foregoing, Distributor specifically agrees that CTT has contracted with Native Energy and Economic Development, LLC for exclusive distribution rights to the Department of Defense, Department of Veterans Affairs and Indian Health Services and Distributor acknowledges it shall have no rights to distribute the Pain Management Therapy Device to any entity covered by said agreement between CTT and Native Energy and Development, LLC.
Right to Distribute. Subject to Licensor's prior written approval, Licensee shall have the right to use distributors to sell Licensed Articles, subject to the following restrictions and requirements: 41 Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc., no. 10.142.41. 42 Confidential information omitted and filed separately with the SEC with a request for confidential treatment by Inter Parfums, Inc., no. 10.142.42. 20 (a) For distribution and sale of Licensed Articles by Licensee into countries, territories or geographic areas other than with respect to (i) the United States and its territories and possessions, including Puerto Rico, or (ii) those countries other than the United States in which the Licensed Xxxx is registered and where Licensor’s Foreign Licensees at any time during the Term operate Nine West Retail Stores in which Licensor’s Foreign Licensees use the Licensed Xxxx in connection with sales of products they are respectively authorized to market, promote and sell, Licensee must submit to Licensor a distribution and sales plan for each such country, territory or other geographic area, which shall be subject to the approval of Licensor in its discretion, setting forth a proposed distributor and/or retailers. Licensee agrees that any such distribution and sales plan shall explicitly provide that with respect to sales of Licensed Articles outside the United States, sales priority will be given by Licensee to Foreign Territories in which there are (A) Nine West Retail Stores owned or operated by Licensor’s Foreign Licensees and (B) department store customers of Licensor’s Foreign Licensees listed in Schedule E-2, as amended from time to time. Licensee further agrees that it will use its best efforts to fully communicate with the respective Licensor’s Foreign Licensees in connection with Licensee’s activities in the respective Foreign Territories and require its respective distributors in (or selling into) Foreign Territories to abide by the requirements set forth in (A) and (B), hereinabove and to fully communicate with the respective Licensor’s Foreign Licensees in those Foreign Territories. Authorization to make sales in additional Foreign Territories by Licensee and/or its distributors shall be requested by Licensee in advance and subject to the prior written approval of Licensor.
Right to Distribute. HBL hereby grants to ABI the exclusive right to distribute product containing HBL IFN-g for inhalation and/or oral use in human species and use by all routes of administration in non-human species worldwide, except Japan." In addition, the first sentence of Section 4, "Term", is hereby amended to read in its entirety as follows: "Unless sooner terminated as hereinafter provided, this Agreement shall remain in effect for a period of thirteen (13) years from the date of this Agreement." No amendments or changes other than the foregoing are made to the Distribution Agreement. The Distribution Agreement, as hereby amended, continues in full force and effect according to its terms.
Right to Distribute. Life Medical shall not grant, directly or indirectly, to any other person any right to use any right or license to use any intellectual property with respect to the Product or the Devices.
